With the ever-increasing role of immune checkpoint inhibitors in the perioperative setting of NSCLC, it is important to understand the heterogeneity and role of PD-L1 expression in early-stage disease, and [18F]FDG-PET/CT may play an important role. The gene discussed is CD274; the disease is non-small cell lung carcinoma.